Thursday, June 20, 2019

VC Deals Only: Cybrexa Therapeutics Completes $13.4M in Series B1...

VC Deals Only: Cybrexa Therapeutics Completes $13.4M in Series B1...: Cybrexa Therapeutics, a New Haven, CT-based biotechnology company developing a new class of cancer therapeutics through its alphalex™ tumor...

No comments:

Post a Comment